Inventor · disambiguated record
Tobias Voigt
Also filed as: VOIGT TOBIAS
7 granted patents·16 pending applications·21 citations·filing 2010–2025
79Inventor score
Files withASCENDIS PHARMA AS12ASCENDIS PHARMA ONCOLOGY DIV A/S4ASCENDIS PHARMA OPHTHALMOLOGY DIV A/S3RAU HARALD2ASCENDIS PHARMA OSTEOARTHRITIS DIV A/S1
Top patents by PatentIndex Score
23 records- 0187US9278139B2Sterilization of biodegradable hydrogelsASCENDIS PHARMA AS·Filed 2015·Granted Mar 8, 2016·7 cites·17 claims
- 0282US8986609B2Sterilization of biodegradable hydrogelsRAU HARALD·Filed 2010·Granted Mar 24, 2015·6 cites·16 claims
- 0379US11642415B2Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2019·Granted May 9, 2023·1 cites·28 claims
- 0474US12246070B2Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2023·Granted Mar 11, 2025·0 cites·4 claims
- 0573US10519226B2VEGF neutralizing prodrugs for the treatment of ocular conditionsASCENDIS PHARMA OPHTHALMOLOGY DIV A/S·Filed 2013·Granted Dec 31, 2019·6 cites·21 claims
- 0666US2023116809A1Prevention and treatment of ocular conditionsASCENDIS PHARMA OPHTHALMOLOGY DIV A/S·Filed 2022·Application pending·0 cites
- 0764US9855340B2Hydrogel prodrugsASCENDIS PHARMA AS·Filed 2013·Granted Jan 2, 2018·1 cites·44 claims
- 0863US2025255973A1Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2025·Application pending·0 cites
- 0962US2023123784A1Biodegradable Polyethylene Glycol Based Water-Insoluble HydrogelsASCENDIS PHARMA AS·Filed 2022·Application pending·0 cites
- 1058US2025387508A1Methods of producing hydrogel microspheresASCENDIS PHARMA AS·Filed 2025·Application pending·0 cites
- 1152US2023241217A1Hydrogel irradiationASCENDIS PHARMA AS·Filed 2021·Application pending·0 cites
- 1251US2015010634A1Prevention and treatment of ocular conditionsASCENDIS PHARMA AS·Filed 2012·Application pending·0 cites
- 1350US2021330798A1Treatment of infectionsASCENDIS PHARMA AS·Filed 2019·Application pending·0 cites
- 1450US2018042996A1Hydrogel-Linked IL-1ra ProdrugASCENDIS PHARMA OSTEOARTHRITIS DIV A/S·Filed 2014·Application pending·0 cites
- 1549US2019262426A1Hydrogel-Linked IL-1ra ProdrugASCENDIS PHARMA AS·Filed 2019·Application pending·0 cites
- 1649US2021330807A1Novel hydrogel conjugatesASCENDIS PHARMA AS·Filed 2019·Application pending·0 cites
- 1749US2025387503A1Drug conjugates for the treatment of ocular disordersASCENDIS PHARMA OPHTHALMOLOGY DIV A/S·Filed 2025·Application pending·0 cites
- 1846US2014243254A1Polymeric Hyperbranched Carrier-Linked ProdrugsHERSEL ULRICH·Filed 2012·Application pending·0 cites
- 1945US2022054476A1Sustained local drug levels for innate immune agonistsASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
- 2045US2022054478A1Minimization of systemic inflammationASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
- 2145US2022054477A1Induction of sustained local inflammationASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
- 2243US11559482B2Biodegradable polyethylene glycol based water-insoluble hydrogelsRAU HARALD·Filed 2010·Granted Jan 24, 2023·0 cites·10 claims
- 2342US2022062273A1Conjugates of pattern recognition receptor agonistsASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tobias Voigt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →